☰

Dave A. Miller, Ph.D. - Publications

Affiliations: 
2007 Pharmaceutics University of Texas at Austin, Austin, Texas, U.S.A. 
Area:
Pharmacy
Tree Info Similar researchers PubMed Report error

40 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Thompson SA, Gala U, Davis DA, Kucera S, Miller D, Williams RO. Can the Oral Bioavailability of the Discontinued Prostate Cancer Drug Galeterone Be Improved by Processing Method? KinetiSol® Outperforms Spray Drying in a Head-to-head Comparison. Aaps Pharmscitech. 24: 137. PMID 37344629 DOI: 10.1208/s12249-023-02597-6  0.398
2023 Thompson SA, Davis DA, Miller DA, Kucera SU, Williams RO. Pre-Processing a Polymer Blend into a Polymer Alloy by KinetiSol Enables Increased Ivacaftor Amorphous Solid Dispersion Drug Loading and Dissolution. Biomedicines. 11. PMID 37238952 DOI: 10.3390/biomedicines11051281  0.378
2023 Corum I, Spangenberg A, Miller K, Kucera S, Miller D. Minimization of Acid-Catalyzed Degradation in KinetiSol Processing through HPMCAS Neutralization. Molecular Pharmaceutics. PMID 36787489 DOI: 10.1021/acs.molpharmaceut.2c00791  0.394
2021 Davis DA, Miller DA, Santitewagun S, Zeitler JA, Su Y, Williams RO. Formulating a heat- and shear-labile drug in an amorphous solid dispersion: Balancing drug degradation and crystallinity. International Journal of Pharmaceutics: X. 3: 100092. PMID 34977559 DOI: 10.1016/j.ijpx.2021.100092  0.381
2021 Gala UH, Miller DA, Su Y, Spangenberg A, Bill Williams RO. The Effect of Drug Loading on the Properties of Abiraterone-Hydroxypropyl Beta Cyclodextrin Solid Dispersions Processed by Solvent Free KinetiSol® Technology. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. PMID 33979662 DOI: 10.1016/j.ejpb.2021.05.001  0.303
2020 Davis DA, Miller DA, Su Y, Williams RO. Thermally Conductive Excipient Expands KinetiSol® Processing Capabilities. Aaps Pharmscitech. 21: 319. PMID 33179174 DOI: 10.1208/s12249-020-01817-7  0.367
2020 Tan DK, Davis DA, Miller DA, Williams RO, Nokhodchi A. Innovations in Thermal Processing: Hot-Melt Extrusion and KinetiSol® Dispersing. Aaps Pharmscitech. 21: 312. PMID 33161479 DOI: 10.1208/s12249-020-01854-2  0.343
2020 Jermain SV, Lowinger MB, Ellenberger DJ, Miller DA, Su Y, Williams Iii RO. and behavior of KinetiSol® and spray dried amorphous solid dispersions of a weakly basic drug and ionic polymer. Molecular Pharmaceutics. PMID 32520562 DOI: 10.1021/Acs.Molpharmaceut.0C00108  0.508
2020 Gala U, Miller D, Williams RO. Improved Dissolution and Pharmacokinetics of Abiraterone through KinetiSol Enabled Amorphous Solid Dispersions. Pharmaceutics. 12. PMID 32295245 DOI: 10.3390/Pharmaceutics12040357  0.52
2019 Gala UH, Miller DA, Williams RO. Harnessing the therapeutic potential of anticancer drugs through amorphous solid dispersions. Biochimica Et Biophysica Acta. Reviews On Cancer. 188319. PMID 31678141 DOI: 10.1016/J.Bbcan.2019.188319  0.401
2019 Jermain SV, Miller D, Spangenberg A, Lu X, Moon C, Su Y, Williams RO. Homogeneity of Amorphous Solid Dispersions - An Example with KinetiSol®. Drug Development and Industrial Pharmacy. 1-35. PMID 30653376 DOI: 10.1080/03639045.2019.1569037  0.514
2018 Ellenberger DJ, Miller DA, Kucera SU, Williams RO. Generation of a Weakly Acidic Amorphous Solid Dispersion of the Weak Base Ritonavir with Equivalent In Vitro and In Vivo Performance to Norvir Tablet. Aaps Pharmscitech. PMID 29869311 DOI: 10.1208/S12249-018-1060-X  0.448
2018 Ellenberger DJ, Miller DA, Williams RO. Expanding the Application and Formulation Space of Amorphous Solid Dispersions with KinetiSol®: a Review. Aaps Pharmscitech. PMID 29846889 DOI: 10.1208/S12249-018-1007-2  0.483
2018 Miller DA. Editorial for Theme Issue: Applications of KinetiSol Dispersing for Advanced Amorphous Solid Dispersions. Aaps Pharmscitech. PMID 29740757 DOI: 10.1208/S12249-018-1016-1  0.361
2018 Ellenberger DJ, Miller DA, Kucera SU, Williams RO. Improved Vemurafenib Dissolution and Pharmacokinetics as an Amorphous Solid Dispersion Produced by KinetiSol® Processing. Aaps Pharmscitech. PMID 29541940 DOI: 10.1208/S12249-018-0988-1  0.52
2017 Keen JM, LaFountaine JS, Hughey JR, Miller DA, McGinity JW. Development of Itraconazole Tablets Containing Viscous KinetiSol® Solid Dispersions: In Vitro and In Vivo Analysis in Dogs. Aaps Pharmscitech. PMID 29192405 DOI: 10.1208/S12249-017-0903-1  0.658
2017 LaFountaine JS, Kumari Prasad L, Miller DA, McGinity JW, Williams RO. Mucoadhesive Amorphous Solid Dispersions for Sustained Release of Poorly Water Soluble Drugs. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. PMID 28088635 DOI: 10.1016/J.Ejpb.2016.12.031  0.679
2017 Keen J, Miller D, Tulloch S. Phase I Trial Results of a Solid Dispersion Formulation of Deferasirox with Enhanced Bioavailability Relative to Exjade® and JadenuTM Blood. 130: 2215-2215. DOI: 10.1182/Blood.V130.Suppl_1.2215.2215  0.397
2016 Brough C, Miller DA, Ellenberger D, Lubda D, Williams RO. Use of Polyvinyl Alcohol as a Solubility Enhancing Polymer for Poorly Water-Soluble Drug Delivery (Part 2). Aaps Pharmscitech. PMID 26863889 DOI: 10.1208/S12249-016-0490-6  0.566
2016 LaFountaine JS, Jermain SV, Prasad LK, Brough C, Miller DA, Lubda D, McGinity JW, Williams RO. Enabling Thermal Processing of Ritonavir-Polyvinyl Alcohol Amorphous Solid Dispersions by KinetiSol(®) Dispersing. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. PMID 26861929 DOI: 10.1016/J.Ejpb.2016.01.018  0.687
2015 LaFountaine JS, Prasad LK, Brough C, Miller DA, McGinity JW, Williams RO. Thermal Processing of PVP- and HPMC-Based Amorphous Solid Dispersions. Aaps Pharmscitech. PMID 26729526 DOI: 10.1208/S12249-015-0417-7  0.677
2015 Brough C, Miller DA, Keen JM, Kucera SA, Lubda D, Williams RO. Use of Polyvinyl Alcohol as a Solubility-Enhancing Polymer for Poorly Water Soluble Drug Delivery (Part 1). Aaps Pharmscitech. PMID 26637232 DOI: 10.1208/S12249-015-0458-Y  0.785
2015 Miller DA, Keen JM, Brough C, Ellenberger DJ, Cisneros M, Williams RO, McGinity JW. Bioavailability enhancement of a BCS IV compound via an amorphous combination product containing ritonavir. The Journal of Pharmacy and Pharmacology. PMID 26454138 DOI: 10.1111/Jphp.12478  0.581
2015 Bennett RC, Brough C, Miller DA, O'Donnell KP, Keen JM, Hughey JR, Williams RO, McGinity JW. Preparation of amorphous solid dispersions by rotary evaporation and KinetiSol Dispersing: approaches to enhance solubility of a poorly water-soluble gum extract. Drug Development and Industrial Pharmacy. 41: 382-97. PMID 24329130 DOI: 10.3109/03639045.2013.866142  0.682
2013 Hughey JR, Keen JM, Miller DA, Kolter K, Langley N, McGinity JW. The use of inorganic salts to improve the dissolution characteristics of tablets containing Soluplus®-based solid dispersions. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 48: 758-66. PMID 23348153 DOI: 10.1016/J.Ejps.2013.01.004  0.646
2012 Hughey JR, Keen JM, Miller DA, Brough C, McGinity JW. Preparation and characterization of fusion processed solid dispersions containing a viscous thermally labile polymeric carrier. International Journal of Pharmaceutics. 438: 11-9. PMID 22960321 DOI: 10.1016/J.Ijpharm.2012.08.032  0.705
2010 Hughey JR, DiNunzio JC, Bennett RC, Brough C, Miller DA, Ma H, Williams RO, McGinity JW. Dissolution enhancement of a drug exhibiting thermal and acidic decomposition characteristics by fusion processing: a comparative study of hot melt extrusion and KinetiSol dispersing. Aaps Pharmscitech. 11: 760-74. PMID 20443089 DOI: 10.1208/S12249-010-9431-Y  0.796
2010 DiNunzio JC, Hughey JR, Brough C, Miller DA, Williams RO, McGinity JW. Production of advanced solid dispersions for enhanced bioavailability of itraconazole using KinetiSol Dispersing. Drug Development and Industrial Pharmacy. 36: 1064-78. PMID 20334539 DOI: 10.3109/03639041003652973  0.8
2010 DiNunzio JC, Brough C, Miller DA, Williams RO, McGinity JW. Applications of KinetiSol dispersing for the production of plasticizer free amorphous solid dispersions. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 40: 179-87. PMID 20230894 DOI: 10.1016/J.Ejps.2010.03.002  0.791
2010 Dinunzio JC, Brough C, Hughey JR, Miller DA, Williams RO, McGinity JW. Fusion production of solid dispersions containing a heat-sensitive active ingredient by hot melt extrusion and Kinetisol dispersing. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fã¼R Pharmazeutische Verfahrenstechnik E.V. 74: 340-51. PMID 19818402 DOI: 10.1016/J.Ejpb.2009.09.007  0.761
2010 DiNunzio JC, Brough C, Miller DA, Williams RO, McGinity JW. Fusion processing of itraconazole solid dispersions by kinetisol dispersing: a comparative study to hot melt extrusion. Journal of Pharmaceutical Sciences. 99: 1239-53. PMID 19681106 DOI: 10.1002/Jps.21893  0.779
2008 DiNunzio JC, Miller DA, Yang W, McGinity JW, Williams RO. Amorphous compositions using concentration enhancing polymers for improved bioavailability of itraconazole. Molecular Pharmaceutics. 5: 968-80. PMID 19434851 DOI: 10.1021/Mp800042D  0.785
2008 Miller DA, DiNunzio JC, Yang W, McGinity JW, Williams RO. Enhanced in vivo absorption of itraconazole via stabilization of supersaturation following acidic-to-neutral pH transition. Drug Development and Industrial Pharmacy. 34: 890-902. PMID 18608468 DOI: 10.1080/03639040801929273  0.782
2008 Yang W, Tam J, Miller DA, Zhou J, McConville JT, Johnston KP, Williams RO. High bioavailability from nebulized itraconazole nanoparticle dispersions with biocompatible stabilizers. International Journal of Pharmaceutics. 361: 177-88. PMID 18556158 DOI: 10.1016/J.Ijpharm.2008.05.003  0.403
2008 Miller DA, Dinunzio JC, Williams RO. Advanced formulation design: improving drug therapies for the management of severe and chronic pain. Drug Development and Industrial Pharmacy. 34: 117-33. PMID 18302030 DOI: 10.1080/03639040701542200  0.674
2008 Miller DA, DiNunzio JC, Yang W, McGinity JW, Williams RO. Targeted intestinal delivery of supersaturated itraconazole for improved oral absorption. Pharmaceutical Research. 25: 1450-9. PMID 18288449 DOI: 10.1007/S11095-008-9543-1  0.78
2008 Fukuda M, Miller DA, Peppas NA, McGinity JW. Influence of sulfobutyl ether beta-cyclodextrin (Captisol) on the dissolution properties of a poorly soluble drug from extrudates prepared by hot-melt extrusion. International Journal of Pharmaceutics. 350: 188-96. PMID 17920217 DOI: 10.1016/J.Ijpharm.2007.08.038  0.559
2007 Overhoff KA, Moreno A, Miller DA, Johnston KP, Williams RO. Solid dispersions of itraconazole and enteric polymers made by ultra-rapid freezing. International Journal of Pharmaceutics. 336: 122-32. PMID 17184938 DOI: 10.1016/J.Ijpharm.2006.11.043  0.552
2007 Miller DA, McConville JT, Yang W, Williams RO, McGinity JW. Hot-melt extrusion for enhanced delivery of drug particles. Journal of Pharmaceutical Sciences. 96: 361-76. PMID 17075869 DOI: 10.1002/Jps.20806  0.634
2007 Miller DA, Gamba M, Sauer D, Purvis TP, Clemens NT, Williams RO. Evaluation of the USP dissolution test method A for enteric-coated articles by planar laser-induced fluorescence. International Journal of Pharmaceutics. 330: 61-72. PMID 17034967 DOI: 10.1016/J.Ijpharm.2006.08.047  0.606
Show low-probability matches.